Webb16 nov. 2005 · Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-127816214597Google ScholarCrossref 11. Law MR, Wald NJ, Thompson SG. WebbWhen it comes to your health, nothing is more valuable than time. Quickly find the best doctors, latest medical advances, and active clinical trials with MediFind. Our goal is to …
Remnant cholesterol, coronary atheroma progression and clinical …
WebbThe 2005 Treating to New Targets (TNT) trial randomized 10,001 patients with CAD and hyperlipidemia to atorvastatin 80 mg or 10 mg PO daily, doses chosen as they were … Webb27 aug. 2024 · Remnant cholesterol has been proposed to promote atherosclerotic cardiovascular disease independent of low-density lipoprotein cholesterol, yet the underlying mechanisms are not well understood. We aimed to study the association of remnant cholesterol with coronary atheroma progression and clinical events. Methods indian buffet in new haven ct
DailyMed - ATORVASTATIN CALCIUM tablet
Webb8 nov. 2016 · Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, et al. Efficacy and safety of more intensive lowering of … Webb1 dec. 2005 · In the TNT trial in patients with stable coronary heart disease (CHD), reduction in LDL-C to 77 mg/dL (2.0 mmol/L) provided greater ASCVD benefit (CHD death, nonfatal MI, fatal or nonfatal... Webb1 aug. 2006 · Four trials were identified: the TNT (Treating to New Targets) and the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid-Lowering) trials involved patients with stable cardiovascular disease, and the PROVE IT–TIMI-22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction … local construction businesses in chelmsford